STAND. COM. REP. NO. 3411

 

Honolulu, Hawaii

                  

 

RE:    H.B. No. 2047

       H.D. 1

       S.D. 1

 

 

 

Honorable Ronald D. Kouchi

President of the Senate

Thirtieth State Legislature

Regular Session of 2020

State of Hawaii

 

Sir:

 

     Your Committee on Commerce, Consumer Protection, and Health, to which was referred H.B. No. 2047, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO HEALTH,"

 

begs leave to report as follows:

 

     The purpose and intent of this measure is to:

 

     (1)  Establish a task force within the Department of Health to identify therapies and home- and community-based care services that may benefit persons having fetal alcohol spectrum disorders, including therapies and treatments that may benefit them as adults; and

 

     (2)  Require the task force to submit a report on its findings and recommendations to the Legislature.

 

     Your Committee received testimony in support of this measure from the State Council on Developmental Disabilities, Hawaii Disability Rights Center, Hawaii Substance Abuse Coalition, Hawaii Psychological Association, and eleven individuals.  Your Committee received comments on this measure from the Department of Human Services, Department of Health, and City and County of Honolulu Liquor Commission.

 

     Your Committee finds that many persons who have been diagnosed with fetal alcohol spectrum disorder face profound challenges in navigating the State's present system of care.  Many individuals with diagnoses on the spectrum cope with lifelong physical, cognitive, or behavioral disabilities but age out of eligibility for care services once they become adults.  This measure helps in the identification of therapies and home- and community-based care services that may benefit persons having fetal alcohol spectrum disorders, including therapies and treatments that may benefit them as adults.

 

     Additionally, your Committee recommends that the task force examine the past sixteen years of legislation relating to fetal alcohol spectrum disorder to provide context for recommendations by the task force in the future.

 

     Your Committee has amended this measure by:

 

     (1)  Clarifying the required parameters of the study conducted by the task force;

 

     (2)  Inserting provisions relating to permitted interaction of members of the task force; and

 

     (3)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

 

     As affirmed by the record of votes of the members of your Committee on Commerce, Consumer Protection, and Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2047, H.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2047, H.D. 1, S.D. 1, and be referred to your Committee on Ways and Means.

 

Respectfully submitted on behalf of the members of the Committee on Commerce, Consumer Protection, and Health,

 

 

 

________________________________

ROSALYN H. BAKER, Chair